Vendor source
Reviewed 28 May 2026
Completeness Strong (75%)
RevealAI-Lung
RevealDxRevealAI™ is Computer Assisted Diagnostic (CADx) software that reveals patterns within images and across patients. The analytics generate scores for the current patient by comparing abnormalities to other patients that have confirmed diagnostics. RevealAI-Lung provides a Malignancy Similarity Index (mSI) from lung CT scans that aids risk assessment. Graphs are provided that help interpret how lung nodules from the current patient relate to confirmed malignant or benign nodules.
Supported by 3 papers
General Information
Product name
Company
Modality
Main task
Not specified
Subspeciality
Disease targeted
Regulatory Information
Pathway:
MDR
Class:
Class IIb
Verified by Health AI Register
Verified by Health AI Register
Other certifications
Not specified
Evidence & Research
Peer-Reviewed Papers
Commercial AI for CT lung cancer screening: product capabilities, coverage of nodule management tasks and supporting evidence
European Radiology · May 2026
A CADx tool improves lung nodule risk stratification when compared to British Thoracic Society guidelines on routine computed tomography (CT)
Clinical Radiology · Oct 2025
Clinical Impact and Generalizability of a Computer-Assisted Diagnostic Tool to Risk-Stratify Lung Nodules With CT
Journal of the American College of Radiology · Sep 2022
Technical Specifications
Patient population age
Not specified
Input
Input format
Output
Output format
Integration
Deployment
Trigger for analysis
Processing time
Population
Market Presence
On market since
AI Platforms
Resellers
Countries present
Not specified
Paying clinical customers
Not specified
Research/test users
Pricing Information
Pricing model
Based on
Source: Vendor | First published: Sep 27, 2022 | Last updated: May 28, 2026